• Patient-Derived Gastric Cancer Assembloids Explained

  2026-09-19

  The 2025 Cancers study developed patient-matched gastric cancer assembloids by combining tumor organoids with stromal cell subpopulations derived from the same tumor. Its findings show that stromal composition changes gene expression and drug sensitivity, supporting more physiologically relevant studies of tumor heterogeneity, resistance, and personalized treatment.

• CHI3L1-IN-5: Translational Leverage in Neuroinflammation

  2026-09-18

  CHI3L1-IN-5, also known as Compound Z17, connects selective CHI3L1 inhibition with inflammatory control and restoration of astrocyte amyloid handling. This thought-leadership analysis translates the available mechanistic and developability evidence into a practical framework for Alzheimer’s disease and neuroinflammation researchers.

• FTH-Driven Ferroptosis in TP53-Mutant Glioblastoma

  2026-09-18

  A 2025 Neuroscience Bulletin study links TP53 gain-of-function signaling to disrupted iron storage in glioblastoma through ITCH-dependent degradation of FTH. The resulting increase in free iron creates a ferroptosis-sensitive state that can be intensified by combining ferric ammonium citrate with erastin, although validation in clinically relevant GBM models remains necessary.

• AZD0156: Practical ATM Kinase Inhibitor Workflows

  2026-09-17

  AZD0156 enables selective interrogation of ATM-dependent DNA damage signaling, checkpoint control, and metabolic adaptation. This workflow-focused guide connects DNA double-strand break assays with macropinocytosis and nutrient-rescue experiments to help cancer researchers distinguish pathway effects from nonspecific toxicity.

• NU7441: DNA-PK Workflows for TDP-43 Studies

  2026-09-17

  NU7441 (KU-57788) provides a selective way to perturb DNA-PK activity while tracking DNA damage, cell-cycle behavior, and TDP-43 homeostasis. This workflow connects established oncology assays with an emerging cytosolic-DNA model, while clearly separating validated product use from exploratory neurobiology.

• AKT Inhibitors: Molecular and Pharmacologic Insights

  2026-09-16

  This systematic study distinguishes how ATP-competitive and allosteric AKT inhibitors engage AKT, influence non-catalytic functions, and respond to isoform-specific mutations. Its combined pharmacology, structural modeling, and phosphoproteomic framework shows why inhibitor class and cellular context are essential when interpreting AKT-directed cancer therapy research.

• Silymarin: Silybin A Workflows for Liver Research

  2026-09-16

  Build reproducible liver research assays with defined Silybin A rather than relying on an unfractionated botanical mixture. This guide combines solvent control, viability-normalized migration testing, oxidative stress reduction workflows, and mechanism-aware interpretation for hepatoprotection, metabolism, fibrosis, and cancer studies.

• Simvastatin (Zocor): Cell Assay Best Practices

  2026-09-15

  A scenario-driven guide to improving Simvastatin cell viability, proliferation, and cytotoxicity assays with SKU A8522. It addresses solubility, dose selection, phenotype interpretation, storage, and supplier evaluation using product data and peer-reviewed evidence.

• GI Device Delivery of mRNA-LNPs in Mice and Pigs

  2026-09-15

  The reference study shows that an ingestible microjet device can deliver firefly luciferase mRNA lipid nanoparticles into gastric and intestinal walls, producing route-dependent expression and biodistribution in mice and minipigs. Its main contribution is not a new mRNA sequence, but evidence that gastrointestinal wall injection can provide systemic and lymphatic exposure while avoiding conventional injections.

• 2-Deoxy-D-glucose: Experimental Workflows

  2026-09-14

  Learn how 2-Deoxy-D-glucose converts glycolytic dependence into measurable experimental endpoints across immune, cancer, and viral models. This workflow-focused guide covers dosing, co-culture design, combination studies, and troubleshooting for reproducible metabolic stress experiments.

• Ibrexafungerp in Resistant Candida auris

  2026-09-14

  Wiederhold and colleagues evaluated ibrexafungerp against Candida auris using susceptibility testing and a delayed-treatment neutropenic mouse model. The study found consistent in vitro activity and improved survival and kidney fungal clearance with higher ibrexafungerp doses, supporting oral glucan synthase inhibition as a strategy for resistant invasive candidiasis while underscoring the limits of preclinical translation.

• C34 TLR4 Inhibitor: Applied Research Workflow

  2026-09-13

  Build cleaner TLR4 experiments with C34, a selective small-molecule control for macrophage, enterocyte, and microglial inflammatory models. This workflow combines dose-response design, pathway selectivity controls, tissue-relevant readouts, and troubleshooting guidance for endotoxemia, necrotizing enterocolitis research, and neuroinflammation studies.

• Protease Inhibitor Cocktail for Lysosome Research

  2026-09-12

  Protect lysosome-repair proteins and native complexes during extraction with an EDTA-free, broad-spectrum formulation. Its 100X DMSO format supports Western blotting, co-immunoprecipitation, phosphorylation analysis, and kinase workflows without intentionally chelating divalent cations.

• Demethyleneberberine: Applied Research Workflows

  2026-09-11

  Demethyleneberberine (DMB) is a versatile research tool for inflammation, neurodegeneration, autoimmune hepatitis, and non-small cell lung cancer models. This workflow-focused guide connects concentration selection, pathway-aware assays, formulation control, and troubleshooting for more reproducible in vitro and in vivo studies.

• Laminin (925-933) Assay Workflow Guide

  2026-09-11

  Laminin (925-933) is a defined Laminin B1 chain peptide for testing receptor-associated cell attachment, migration, and chemotaxis without the structural complexity of full-length laminin. This guide covers preparation, assay controls, and troubleshooting; the peptide is for in vitro research and should not be treated as a diagnostic, therapeutic, or broadly validated metastasis intervention.

8575 records 1/572 page Next 12345 下5页 Last page